Insider Stock Trading History of Cagle Gerald D.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Cagle Gerald D. since year 2005. The trader's CIK number is 1589991. At the time of this reporting, Cagle Gerald D. is the Director of Aerie Pharmaceuticals Inc . (stock ticker symbol AERI). See this page for all insider trading activities at Aerie Pharmaceuticals Inc .

Note that in the past Cagle Gerald D. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Cagle Gerald D. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-05-25 AERI Aerie Pharmaceuticals Inc Buy 1,000 49.45 49,450
2018-05-21 AERI Aerie Pharmaceuticals Inc Buy 1,000 50.24 50,245
2018-05-11 CLSD Clearside Biomedical, Inc. Option Ex 45,454 .40 18,181
2018-03-22 CLSD Clearside Biomedical, Inc. Buy 7,500 11.89 89,175
2017-08-11 CLSD Clearside Biomedical, Inc. Buy 5,000 7.08 35,400
2017-05-09 AERI Aerie Pharmaceuticals Inc Buy 1,000 39.90 39,900
2017-03-27 CLSD Clearside Biomedical, Inc. Buy 14,064 7.10 99,854
2017-04-19 AERI Aerie Pharmaceuticals Inc Buy 2,000 41.70 83,400
2017-03-16 CLSD Clearside Biomedical, Inc. Buy 5,000 6.84 34,200
2016-06-07 CLSD Clearside Biomedical, Inc. Sale 2 7.00 14
2015-02-04 AERI Aerie Pharmaceuticals Inc Buy 500 25.60 12,800
2015-02-05 AERI Aerie Pharmaceuticals Inc Buy 500 24.54 12,270
2015-08-10 AERI Aerie Pharmaceuticals Inc Buy 1,146 16.35 18,735
2015-08-12 AERI Aerie Pharmaceuticals Inc Buy 500 15.46 7,729
2015-08-28 AERI Aerie Pharmaceuticals Inc Buy 2,000 16.60 33,200
2014-05-16 AERI Aerie Pharmaceuticals Inc Buy 1,854 15.07 27,939

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cagle Gerald D. (Director of Aerie Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.